Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2023
Filter by date:
Showing 1239 press releases before 2023
-
Results from Two Phase II Trials Add to Understanding of Brilinta (Ticagrelor) and How it Works in the Body
-
BRILINTA Demonstrated Greater Efficacy Over Clopidogrel in the Most Urgent Clinical Setting: Patients with ST-Segment Elevation Myocardial Infarction and Planned Percutaneous Coronary Intervention (PCI)
-
Discovery Research Leader Leaves AstraZeneca
-
AstraZeneca PLC Third Quarter & Nine Months Results 2009
-
AstraZeneca withdraws regulatory submissions for Zactima (vandetanib) in combination with chemotherapy for advanced NSCLC
-
Patients Taking VIMOVO(TM) Showed Decrease in incidence of NSAID Associated Ulcers
-
AstraZeneca Submits Marketing Authorisation Application to European Union for VIMOVO™
-
US Food and Drug Administration Approves CRESTOR for Use in Pediatric Patients with Heterozygous Familial Hypercholesterolemia
-
Study Finds That ONGLYZA (saxagliptin) When Added to Metformin was Non-Inferior to Januvia (sitagliptin) When Added to Metformin in Reducing Hemoglobin (HbA1c) in Adults with Type 2 Diabetes Mellitus
-
ONGLYZA (saxagliptin) Receives Marketing Authorisation in Europe for the Treatment of Type 2 Diabetes
Latest articles and press releases
All of our latest press releases and articles are available to explore
